IMMUNOGLOBULIN E - ANVISA Registration 80105220273
Access comprehensive regulatory information for IMMUNOGLOBULIN E in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80105220273 and manufactured by AESKU DIAGNOSTICS GMBH & CO. KG. The registration is held by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including PHADIA AB, SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80105220273
25351075273202515
04299232000143
Company Information
Dates and Status
Jun 16, 2025
VIGENTE
09/18/2025 19:00:01
IMUNOGLOBULINA E
Celer Finecare IgE Teste Quantitativo
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410147
Jul 14, 2025
IMUNOGLOBULINA E
AESKUCARE® Allergy TWO
AESKU DIAGNOSTICS GMBH & CO. KG
80105220274
Jun 16, 2025
IMUNOGLOBULINA E
AESKUCARE® Allergy FOUR
AESKU DIAGNOSTICS GMBH & CO. KG
80105220275
Jun 16, 2025
IMUNOGLOBULINA E
AESKUCARE® Allergy THREE
AESKU DIAGNOSTICS GMBH & CO. KG
80105220276
Jun 16, 2025
IMUNOGLOBULINA E
Família Imunoglobulina E (IgE)
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390321
Jun 09, 2025

